Literature DB >> 17212655

Extracellular domain splice variants of a transforming protein tyrosine phosphatase alpha mutant differentially activate Src-kinase dependent focus formation.

Katja Kapp1, Jan Siemens, Peter Weyrich, Jörg B Schulz, Hans-Ulrich Häring, Reiner Lammers.   

Abstract

The extracellular domains of receptor-type protein-tyrosine phosphatases (PTPs) contain a diverse range of protein modules like fibronectin- or immunoglobulin-like structures. These are frequently expressed in a tissue- and development specific manner as splice variants. The extracellular domain of PTPalpha is rather short and heavily glycosylated. Two splice variants are known, which it differs by an exon encoding nine amino acids within the extracellular domain. We have analyzed the expression pattern of both variants and found that the smaller form is ubiquitously expressed while the larger form was found at an increased level only in brain, some skeletal muscle and differentiating cells like granule neurons, adipocytes and myotubes. The phosphatase activity of both forms was similar when tested in vitro using para-nitrophenylphosphate as a substrate and in a transient expression system with the substrates c-Fyn or c-Src. In a quantitative focus formation assay the capability of the larger form to activate Src-dependent focus formation in intact cells was increased more than twofold whereas the capability to dephosphorylate the insulin receptor in a BHK cell system was similar. We conclude that the two splice variants of PTPalpha are expressed differentially and regulate c-Src activity in different ways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17212655     DOI: 10.1111/j.1365-2443.2006.01034.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  6 in total

1.  Loss of function studies in mice and genetic association link receptor protein tyrosine phosphatase α to schizophrenia.

Authors:  Nagahide Takahashi; Karin Sandager Nielsen; Branko Aleksic; Steffen Petersen; Masashi Ikeda; Itaru Kushima; Nathalie Vacaresse; Hiroshi Ujike; Nakao Iwata; Véronique Dubreuil; Naheed Mirza; Takeshi Sakurai; Norio Ozaki; Joseph D Buxbaum; Jan Sap
Journal:  Biol Psychiatry       Date:  2011-08-10       Impact factor: 13.382

2.  Serine dephosphorylation of receptor protein tyrosine phosphatase alpha in mitosis induces Src binding and activation.

Authors:  Andrei M Vacaru; Jeroen den Hertog
Journal:  Mol Cell Biol       Date:  2010-04-12       Impact factor: 4.272

3.  Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.

Authors:  Gwendlyn Kollmorgen; Gerhard Niederfellner; Alexander Lifke; Gloria J Spohn; Natascha Rieder; Suzana Vega Harring; Frieder Bauss; Helmut Burtscher; Reiner Lammers; Birgit Bossenmaier
Journal:  Mol Oncol       Date:  2013-09-03       Impact factor: 6.603

4.  Extracellular domain dependence of PTPalpha transforming activity.

Authors:  Barbara Tremper-Wells; Ross J Resnick; Xinmin Zheng; Leslie J Holsinger; David Shalloway
Journal:  Genes Cells       Date:  2010-06-07       Impact factor: 1.891

5.  Activation of Src and transformation by an RPTPα splice mutant found in human tumours.

Authors:  Jian Huang; Ling Yao; Rongting Xu; Huacheng Wu; Min Wang; Brian S White; David Shalloway; Xinmin Zheng
Journal:  EMBO J       Date:  2011-07-01       Impact factor: 11.598

6.  Does a rare mutation in PTPRA contribute to the development of Parkinson's disease in an Australian multi-incident family?

Authors:  Melissa A Hill; Steven R Bentley; Tara L Walker; George D Mellick; Stephen A Wood; Alex M Sykes
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.